Cargando…

Design of Cocaethylene and Cocaine Conjugates to Produce Highly Selective Polyclonal Antibodies

With the aim to obtain specific anti-cocaine antibodies directed against cocaine and active metabolites for use in immunotherapy, a series of six haptens were prepared, based on the structure of cocaine. The haptens differed by 3 positions of linkers: nitrogen, carboxyl group, and aromatic nucleus....

Descripción completa

Detalles Bibliográficos
Autores principales: Gadjou, Caroline, Danger, Yannic, Sandouk, Pierre, Scherrmann, Jean-Michel, Blanchard, Dominique, Folléa, Gilles, Galons, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Master Publishing Group 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614565/
https://www.ncbi.nlm.nih.gov/pubmed/23674968
_version_ 1782264865295958016
author Gadjou, Caroline
Danger, Yannic
Sandouk, Pierre
Scherrmann, Jean-Michel
Blanchard, Dominique
Folléa, Gilles
Galons, Hervé
author_facet Gadjou, Caroline
Danger, Yannic
Sandouk, Pierre
Scherrmann, Jean-Michel
Blanchard, Dominique
Folléa, Gilles
Galons, Hervé
author_sort Gadjou, Caroline
collection PubMed
description With the aim to obtain specific anti-cocaine antibodies directed against cocaine and active metabolites for use in immunotherapy, a series of six haptens were prepared, based on the structure of cocaine. The haptens differed by 3 positions of linkers: nitrogen, carboxyl group, and aromatic nucleus. The haptens were grafted onto 3 carrier proteins: bovine serum albumin, tetanus toxoid or keyhole limpet hemocyanin according to different methods of coupling: carbodiimide or mixed anhydride techniques. The immuno-conjugates were administered to rabbits and the antisera elicited were analyzed in term of titer, affinity and specificity. Variation in antisera properties were observed and attributed to the site of coupling the hapten, to the carrier proteins, and to the method of coupling. Antisera titers were in the range of 1/1 (no significant response) to 1/12,832, with antisera affinity up to 5.9 × 10(11) M-1. This strategy allowed the selection of a new hapten, which after coupling on carrier proteins, led to the production of antisera with a high specificity toward cocaine and cocaethylene, but exclude the inactive metabolites of cocaine.
format Online
Article
Text
id pubmed-3614565
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Master Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-36145652013-05-01 Design of Cocaethylene and Cocaine Conjugates to Produce Highly Selective Polyclonal Antibodies Gadjou, Caroline Danger, Yannic Sandouk, Pierre Scherrmann, Jean-Michel Blanchard, Dominique Folléa, Gilles Galons, Hervé Int J Biomed Sci Article With the aim to obtain specific anti-cocaine antibodies directed against cocaine and active metabolites for use in immunotherapy, a series of six haptens were prepared, based on the structure of cocaine. The haptens differed by 3 positions of linkers: nitrogen, carboxyl group, and aromatic nucleus. The haptens were grafted onto 3 carrier proteins: bovine serum albumin, tetanus toxoid or keyhole limpet hemocyanin according to different methods of coupling: carbodiimide or mixed anhydride techniques. The immuno-conjugates were administered to rabbits and the antisera elicited were analyzed in term of titer, affinity and specificity. Variation in antisera properties were observed and attributed to the site of coupling the hapten, to the carrier proteins, and to the method of coupling. Antisera titers were in the range of 1/1 (no significant response) to 1/12,832, with antisera affinity up to 5.9 × 10(11) M-1. This strategy allowed the selection of a new hapten, which after coupling on carrier proteins, led to the production of antisera with a high specificity toward cocaine and cocaethylene, but exclude the inactive metabolites of cocaine. Master Publishing Group 2006-02 /pmc/articles/PMC3614565/ /pubmed/23674968 Text en © Gadjou et al. Licensee Master Publishing Group http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Gadjou, Caroline
Danger, Yannic
Sandouk, Pierre
Scherrmann, Jean-Michel
Blanchard, Dominique
Folléa, Gilles
Galons, Hervé
Design of Cocaethylene and Cocaine Conjugates to Produce Highly Selective Polyclonal Antibodies
title Design of Cocaethylene and Cocaine Conjugates to Produce Highly Selective Polyclonal Antibodies
title_full Design of Cocaethylene and Cocaine Conjugates to Produce Highly Selective Polyclonal Antibodies
title_fullStr Design of Cocaethylene and Cocaine Conjugates to Produce Highly Selective Polyclonal Antibodies
title_full_unstemmed Design of Cocaethylene and Cocaine Conjugates to Produce Highly Selective Polyclonal Antibodies
title_short Design of Cocaethylene and Cocaine Conjugates to Produce Highly Selective Polyclonal Antibodies
title_sort design of cocaethylene and cocaine conjugates to produce highly selective polyclonal antibodies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614565/
https://www.ncbi.nlm.nih.gov/pubmed/23674968
work_keys_str_mv AT gadjoucaroline designofcocaethyleneandcocaineconjugatestoproducehighlyselectivepolyclonalantibodies
AT dangeryannic designofcocaethyleneandcocaineconjugatestoproducehighlyselectivepolyclonalantibodies
AT sandoukpierre designofcocaethyleneandcocaineconjugatestoproducehighlyselectivepolyclonalantibodies
AT scherrmannjeanmichel designofcocaethyleneandcocaineconjugatestoproducehighlyselectivepolyclonalantibodies
AT blancharddominique designofcocaethyleneandcocaineconjugatestoproducehighlyselectivepolyclonalantibodies
AT folleagilles designofcocaethyleneandcocaineconjugatestoproducehighlyselectivepolyclonalantibodies
AT galonsherve designofcocaethyleneandcocaineconjugatestoproducehighlyselectivepolyclonalantibodies